Outcomes After Current Transcatheter Tricuspid Valve Intervention
Top Cited Papers
- 26 December 2018
- journal article
- research article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 12 (2), 155-165
- https://doi.org/10.1016/j.jcin.2018.10.022
Abstract
No abstract availableFunding Information
- Boston Scientific Corporation
- Medtronic
- Biotronik
- St. Jude Medical
- Abbott Laboratories
- Amgen
- Edwards Lifesciences
This publication has 26 references indexed in Scilit:
- Clipping of the tricuspid valve: proposal of a “Rosetta Stone” nomenclature for procedural 3D transoesophageal guidanceEuroIntervention, 2017
- Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitationEuropean Heart Journal, 2017
- Transcatheter interventions for tricuspid regurgitation: TriCinch (4Tech)EuroIntervention, 2016
- Diagnosis and treatment of tricuspid valve disease: current and future perspectivesThe Lancet, 2016
- Percutaneous tricuspid valve therapies: the new frontierEuropean Heart Journal, 2016
- Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint DefinitionsJournal of the American College of Cardiology, 2015
- Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular ImagingEuropean Heart Journal – Cardiovascular Imaging, 2013
- Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational studyEuropean Heart Journal, 2013
- Determinants of Recurrent or Residual Functional Tricuspid Regurgitation After Tricuspid AnnuloplastyCirculation, 2006
- Tricuspid valve repair: durability and risk factors for failureThe Journal of Thoracic and Cardiovascular Surgery, 2004